Pancreatic Cancer Research

ResearcherNational Hospital OrganizationActive in the last 2 years

Kimitoshi Kubo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1424-1011; OpenAlex author ID A5108952415. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Gastric Adenosquamous Carcinoma Mimicking Pancreatic Cancer. Co-author DOI 10.1016/j.gastha.2024.06.008↗
  2. Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer. Co-author DOI 10.21037/jgo.2017.02.02↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Noriko Kimura · 1 shared paper, 2024 · strength 0.36
  2. Masaki Kuwatani · 1 shared paper, 2017 · strength 0.06
  3. Yoshito Komatsu · 1 shared paper, 2017 · strength 0.06
  4. Tetsuhito Muranaka · 1 shared paper, 2017 · strength 0.06
  5. Yasuyuki Kawamoto · 1 shared paper, 2017 · strength 0.06
  6. Kazumichi Kawakubo · 1 shared paper, 2017 · strength 0.06
  7. Naoya Sakamoto · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.